Legal Opinion
Genzyme Therapeutic Products Ltd. Partnership v. Biomarin Pharmaceutical Inc.
Court of Appeals for the Federal Circuit
Decided June 14, 2016No. 2015-1720, 2015-1721PublishedCited by 29 opinions
1Opinion of the Court
BRYSON, Circuit Judge.
This is an appeal from decisions of the Patent Trial and Appeal Board in two inter partes review proceedings. At the behest of petitioner Biomarin Pharmaceutical Inc. (“Biomarin”), the Board held various claims of two patents owned by Genzyme Therapeutics Products Limited Partnership (“Genzyme”) to be unpatentable as obvious. We affirm.
I
A
The patents at issue in this case, U.S. Patent Nos. 7,351,410 (“the ’410 patent”) and 7,655,226 (“the ’226 patent”), are both entitled “Treatment of Pompe’s Disease” and are directed to treating Pompe’s disease with injections of human…
2Cases cited13 opinions
- Litton Industrial Products, Inc., Appellant/cross-Appellee v. Solid State Systems Corp., Appellee/cross-AppellantCourt of Appeals for the Federal Circuit · 1985
- Belden Inc. v. Berk-Tek LLCCourt of Appeals for the Federal Circuit · 2015
- In Re Cuozzo Speed Technologies, LLCCourt of Appeals for the Federal Circuit · 2015
- Ariosa Diagnostics v. Verinata Health, Inc.Court of Appeals for the Federal Circuit · 2015
- Rodale Press, Inc. v. Federal Trade CommissionCourt of Appeals for the D.C. Circuit · 1968
8 more not listed; retrieve them via the Exa API.
3Cited by29 opinions
- Novartis AG v. Torrent Pharmaceuticals Ltd.Court of Appeals for the Federal Circuit · 2017
- Skky, Inc. v. Mindgeek, S.A.R.L.Court of Appeals for the Federal Circuit · 2017
- In Re: Nuvasive, Inc.Court of Appeals for the Federal Circuit · 2016
- Westerngeco LLC v. Ion Geophysical Corp. (In Re Westerngeco LLC)Court of Appeals for the Federal Circuit · 2018
- Koninklijke Philips N v. v. Google LLCCourt of Appeals for the Federal Circuit · 2020
24 more not listed; retrieve them via the Exa API.